Pharmaceutical law

Pharmaceutical law regulation of research, development, and marketing editor-in-chief, Michael E. Clark. - Arlington, Va Bureau of National Affairs c2007. - xlvi, 853 p. 26 cm.

"American Bar Association, Health Law Section"

Includes bibliographical references and index.

Statutory and regulatory controls for drug development -- Key federal agencies regulating pharmaceuticals -- Federal regulation of advertising, promotion, and distribution practices -- Potential liability for drug companies, health care providers and insurers: off-label prescribing and internet advertising -- Federal regulation of clinical research -- Avoiding fraud and abuse penalties and sanctions -- Regulation of privacy under hipaa and other privacy laws -- Federal sentencing guidelines and compliance measures -- The FDA approval process for new drugs -- State regulatory schemes for pharmaceuticals and related issues -- Antitrust and intellectual law issues for pharmaceutical companies -- Securities law issues and disclosure considerations for pharmaceutical companies.

9781570185762 (alk. paper) 157018576X (alk. paper)

2007033206


Pharmacy--Law and legislation--United States.
Drug development--United States.
Pharmaceutical Industry--United States.
Drugs--Law and legislation--United States.

KF 2915 .P4 / P495 2007
logopucpr-y-vive

Contáctanos

¡Queremos saber de ti!

Tel. 787.841.2000 Ext. 1801

bibliotecavaldes@pucpr.edu

⁣Búscanos en las redes

© 2026 Desarrollado por Ignite Online • All Rights Reserved • Powered by Koha.